To gather further insights in the intersection of cell therapy and immunology, we welcome articles addressing, but not limited to, the following themes: - Construction of CAR or other engineered T ...

3,4 Despite the requirement of continued therapy to achieve a benefit with golimumab and baricitinib, these interventions modified the course of type 1 diabetes, resulting in reduced insulin need, ...

Obe-cel was designed to increase T-cell persistence and reduce T-cell exhaustion and was shown to improve response rates and survival, particularly in patients with low leukemia burden.

Scientists investigated how an inherited genetic variation common among East Asians contributes to drug resistance in cancer cells, driving more aggressive cancer growth. The team trialled a precision ...

The University of Texas MD Anderson Cancer Center today announced the launch of its Institute for Cell Therapy Discovery & Innovation, which will build upon longstanding MD Anderson clinical and ...

The process of identifying promising small molecule drug candidates that target cancer checkpoints may become faster and ...

Updated clinical data from VISTA101 presented at SITC 2024.Monotherapy arm fully enrolled and combination arm expected to be fully enrolled by ...

Summit Therapeutics may have a powerful new cancer therapy on its hands. Merck is milking its cash cow oncology drug ... In ...

While Moderna’s Spikevax beat Wall Street estimates in the third quarter, William Blair analyst Myles Minter in a Thursday ...

Graybosch covers the Healthcare sector, focusing on stocks such as Merck & Company, Arcus Biosciences ... It is assembling a portfolio of allogeneic iNK and iT cell therapy product candidates across ...

Despite the potential in oncology, BNTX's current valuation is high relative to its non-COVID revenue prospects, warranting a ...

Bionomics shares are trading higher by 104% Tuesday morning. The company announced a AUD$1 million milestone payment from ...